Aggarwal, R. R., Lloyd, P., Huang, J., Beer, T. M., Zhang, L., Thomas, G. V., … Small, E. J. (2018). DNA repair mutations and treatment-emergent small cell neuroendocrine prostate cancer (t-SCNC) as hallmarks of distinct subgroups of metastatic castration resistant prostate cancer (mCRPC): Data from the West Coast Prostate Cancer Dream Team. In Journal of Clinical Oncology (Vol. 36, pp. 5039–5039). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2018.36.15_suppl.5039

Aggarwal, Rahul Raj, Paul Lloyd, Jiaoti Huang, Tomasz M. Beer, Li Zhang, George V. Thomas, Lawrence D. True, et al. “DNA repair mutations and treatment-emergent small cell neuroendocrine prostate cancer (t-SCNC) as hallmarks of distinct subgroups of metastatic castration resistant prostate cancer (mCRPC): Data from the West Coast Prostate Cancer Dream Team.” In Journal of Clinical Oncology, 36:5039–5039. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.5039.

Aggarwal RR, Lloyd P, Huang J, Beer TM, Zhang L, Thomas GV, et al. DNA repair mutations and treatment-emergent small cell neuroendocrine prostate cancer (t-SCNC) as hallmarks of distinct subgroups of metastatic castration resistant prostate cancer (mCRPC): Data from the West Coast Prostate Cancer Dream Team. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 5039–5039.

Aggarwal, Rahul Raj, et al. “DNA repair mutations and treatment-emergent small cell neuroendocrine prostate cancer (t-SCNC) as hallmarks of distinct subgroups of metastatic castration resistant prostate cancer (mCRPC): Data from the West Coast Prostate Cancer Dream Team.” Journal of Clinical Oncology, vol. 36, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2018, pp. 5039–5039. Crossref, doi:10.1200/jco.2018.36.15_suppl.5039.

Aggarwal RR, Lloyd P, Huang J, Beer TM, Zhang L, Thomas GV, True LD, Alumkal JJ, Friedl V, Weinstein A, Reiter RE, Rettig M, Lara P, Gleave M, Foye A, Playdle D, Feng FY, Chi KN, Stuart J, Small EJ. DNA repair mutations and treatment-emergent small cell neuroendocrine prostate cancer (t-SCNC) as hallmarks of distinct subgroups of metastatic castration resistant prostate cancer (mCRPC): Data from the West Coast Prostate Cancer Dream Team. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 5039–5039.